Stay updated on Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.

Latest updates to the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page
- CheckyesterdayChange DetectedStudy location list updated with new sites across the United States, Europe, and other regions. Several previously listed locations have been removed.SummaryDifference3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe PubMed publications description was updated to indicate that publications are auto-filled from PubMed and may not be about the study. The revision tag was changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check37 days agoChange DetectedThe general government operating status notice is removed from the page. This change does not alter trial details, eligibility criteria, or outcomes.SummaryDifference0.2%

- Check51 days agoChange DetectedNo significant content changes detected on the Study Details page; the study overview, eligibility criteria, design, and locations appear unchanged.SummaryDifference0.2%

- Check80 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

- Check87 days agoChange DetectedAdded new version tag v3.1.0 and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, plus an earlier version v3.0.2). The core effect is a reorganization that reduces coverage of safety topics.SummaryDifference0.2%

Stay in the know with updates to Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.